StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AGRIBIO.BO$293.55+1.83%
Fair $293.55+0.0%

AGRIBIO.BO

Agribio Spirits Limited

Consumer Cyclical / Textile ManufacturingBSE

$293.55

+5.45 (+1.83%)

Fairly Valued+0.0%Fair Value $293.55Fund rank 25/100 · Data gapFallback financials|
SA 49/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-49.2M · quality 51.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 10/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · AGRIBIO.BOLocal privado en este navegador · Agribio Spirits Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.2B

P/E

84.8x

↑

EV/EBITDA

69.9x

↑

ROE

5.5%

↑

Gross Margin

1.2%

↓

Debt/Equity

0.03

↓
52-Week Range$294
$178$314

TradingView lightweight chart

AGRIBIO.BO price, volumen y niveles de valoración

Último $303.50Periodo +144.1%
Fair value: $293.55

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

-27.0%

FCF / Net income

-1.33x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $181.9M · net income $36.9M · FCF $-49.2M

2022-FY → 2025-FY

Gross margin

1.2%— pts

Operating margin

5.4%— pts

Net margin

20.3%— pts

FCF margin

-27.0%— pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$181.9M$181.9M$205.1M$181.0M—
Net Income$36.9M$36.9M$31.7M$24.6M$15.7M
EBITDA$43.5M$43.5M$36.6M$27.9M$17.4M
EPS3.583.584.123.202.04
Gross Margin1.2%1.2%2.9%4.3%—
Operating Margin5.4%5.4%3.2%4.0%—
Net Margin20.3%20.3%15.4%13.6%—
Balance Sheet
Debt/Equity0.030.030.050.040.05
Cash Flow
Free Cash Flow$-49.2M$-49.2M$-119.8M$84000.00$60.5M
Returns
ROE5.5%5.5%6.6%16.0%9.4%
Valuation
P/E84.8484.84———
EV/EBITDA69.9169.91———
P/B4.554.55———
Growth & Yield
Revenue Growth-11.3%-11.3%13.3%——
EPS Growth-13.1%-13.1%28.7%56.9%—
Dividend Yield0.1%0.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

93.8%

muy exigente

EPS terminal req.

$26.05

Spread vs growth

-106.9%

5Y implied EPS CAGR

54.5%

muy exigente

EPS terminal req.

$31.52

Spread vs growth

-67.6%

10Y implied EPS CAGR

30.4%

muy exigente

EPS terminal req.

$50.76

Spread vs growth

-43.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +66.7%

Total return

+66.7%

Start / end P/E

44.2x → 84.8x

EPS bridge

4.12 → 3.58

Residual

-12.0%

EPS growth-13.1%
Multiple rerating+91.7%
Dividend+0.1%
Residual / FX / buybacks / cross-term-12.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.